Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Endogenous neuropeptide, involved in nociceptio...
Diterpene found in brewed, unfiltered coffee; F...
Inhibitor of EGFR, HER2, VEGFR2, and FLT3.
Modifies microvascular function
Tyrphostin; VEGFR inhibitor.
Chk1 inhibitor.
Amino acid alcohol.
Agonist of STING.
EGFR2 inhibitor.
Nucleoside (thymidine) analog; DNA chain termin...
Endogenous neuropeptide hormone, lowers extrace...
STAT3 inhibitor.
V2 antagonist.
Peptide, contains two cell-penetrating sequence...
NSAID; COX-1/2 inhibitor.
Ca2+-sensing receptor antagonist.
HDAC inhibitor.
Water-soluble coenzyme, vitamin (B7) found in v...
Folic acid derivative
Cyclic sesquiterpene found in ginger root; pote...